Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Lammers currently holds 2,001 shares of Salarius Pharmaceuticals, Inc. (SLRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Lammers has been a net neutral trader of SLRX stock. They have purchased $0 and sold $0 worth of shares.
Paul Lammers's most recent insider trade was on Aug 31, 2026, when they sold 2,000 shares at $0.00 per share.
Paul Lammers serves as Executive at Salarius Pharmaceuticals, Inc. (SLRX). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Paul Lammers holds the position of Executive at Salarius Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Paul Lammers has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Paul Lammers was on Aug 31, 2026, when they purchased $0 worth of DCOY shares. This transaction involved 2,000 shares at N/A per share.
Paul Lammers currently owns 2,001 shares of Salarius Pharmaceuticals, Inc. (SLRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Lammers's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Lammers has 3 Form 4 filings on record as an insider at Salarius Pharmaceuticals, Inc..
Set alerts for Paul Lammers and 40,000+ other insiders.